IDEAS home Printed from https://ideas.repec.org/r/cup/cbooks/9780521858229.html
   My bibliography  Save this item

Knowledge Accumulation and Industry Evolution

Citations

Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
as


Cited by:

  1. Elena Cefis & Orietta Marsili & Hans Schenk, 2009. "The effects of mergers and acquisitions on the firm size distribution," Journal of Evolutionary Economics, Springer, vol. 19(1), pages 1-20, February.
  2. Gianluca Capone & Franco Malerba & Richard R. Nelson & Luigi Orsenigo & Sidney G. Winter, 2019. "History friendly models: retrospective and future perspectives," Eurasian Business Review, Springer;Eurasia Business and Economics Society, vol. 9(1), pages 1-23, March.
  3. Darío Vázquez, 2020. "Variety patterns in defense and health technological systems: evidence from international trade data," Journal of Evolutionary Economics, Springer, vol. 30(4), pages 949-988, September.
  4. Timothy F. Bresnahan & Shane Greenstein & Rebecca M. Henderson, 2011. "Schumpeterian Competition and Diseconomies of Scope: Illustrations from the Histories of Microsoft and IBM," NBER Chapters, in: The Rate and Direction of Inventive Activity Revisited, pages 203-271, National Bureau of Economic Research, Inc.
  5. Havas, Attila, 2010. "Diversity in firms’ innovation strategies and activities: Main findings of interviews and implications in the context of the Hungarian national," MPRA Paper 55852, University Library of Munich, Germany.
  6. Lazonick, William & Tulum, Öner, 2011. "US biopharmaceutical finance and the sustainability of the biotech business model," Research Policy, Elsevier, vol. 40(9), pages 1170-1187.
  7. Filippo Belloc, 2014. "Innovation in State-Owned Enterprises: Reconsidering the Conventional Wisdom," Journal of Economic Issues, Taylor & Francis Journals, vol. 48(3), pages 821-848.
  8. Taalbi, Josef, 2015. "Development Blocks in Innovation Networks. The Swedish Manufacturing Industry, 1970-2007," MPRA Paper 64549, University Library of Munich, Germany, revised 23 May 2015.
  9. Höglinger, Christoph & Sinozic, Tanja & Tödtling, Franz, 2012. "Emergence, growth and transformation in local clusters - Environmental industries in the region of Upper Austria," SRE-Discussion Papers 2012/07, WU Vienna University of Economics and Business.
  10. Lorenz, Steffi, 2015. "Diversität und Verbundenheit der unternehmerischen Wissensbasis: Ein neuartiger Messansatz mit Indikatoren aus Innovationsprojekten," Discussion Papers on Strategy and Innovation 15-01, Philipps-University Marburg, Department of Technology and Innovation Management (TIM).
  11. Stephan, Michael, 2013. "Theorien der Industrieevolution," Discussion Papers on Strategy and Innovation 13-03, Philipps-University Marburg, Department of Technology and Innovation Management (TIM).
  12. Garavaglia Christian & Malerba Franco & Orsenigo Luigi & Pezzoni Michele, 2014. "Innovation and Market Structure in Pharmaceuticals: An Econometric Analysis on Simulated Data," Journal of Economics and Statistics (Jahrbuecher fuer Nationaloekonomie und Statistik), De Gruyter, vol. 234(2-3), pages 274-298, April.
  13. Maureen McKelvey & Bastian Rake, 2012. "Research Network Position and Innovative Performance: Evidence from the Pharmaceutical Industry," Jena Economics Research Papers 2012-021, Friedrich-Schiller-University Jena.
  14. Federico Stezano, 2019. "Industrial and Innovation Policies in the Mexican Biotechnology Sector," Journal of Industry, Competition and Trade, Springer, vol. 19(1), pages 123-140, March.
  15. Giovanni Dosi, 2021. "Policy Lessons From Medical Responses to the COVID-19 Crisis," Intereconomics: Review of European Economic Policy, Springer;ZBW - Leibniz Information Centre for Economics;Centre for European Policy Studies (CEPS), vol. 56(6), pages 337-340, November.
  16. Jakob Hoffmann & Johannes Glückler, 2023. "Technological Cohesion and Convergence: A Main Path Analysis of the Bioeconomy, 1900–2020," Sustainability, MDPI, vol. 15(16), pages 1-17, August.
  17. Jenn hwan Wang & Tsung-Yuan Chen & Ching-Jung Tsai, 2012. "In Search of an Innovative State: The Development of the Biopharmaceutical Industry in Taiwan, South Korea and China," Development and Change, International Institute of Social Studies, vol. 43(2), pages 481-503, March.
  18. Nuvolari, Alessandro & Russo, Emanuele, 2019. "Technical progress and structural change: a long-term view," MERIT Working Papers 2019-022, United Nations University - Maastricht Economic and Social Research Institute on Innovation and Technology (MERIT).
  19. Stefan Krätke, 2014. "Global Pharmaceutical and Biotechnology Firms’ Linkages in the World City Network," Urban Studies, Urban Studies Journal Limited, vol. 51(6), pages 1196-1213, May.
  20. Safarzyńska, Karolina & Frenken, Koen & van den Bergh, Jeroen C.J.M., 2012. "Evolutionary theorizing and modeling of sustainability transitions," Research Policy, Elsevier, vol. 41(6), pages 1011-1024.
  21. Tino Schütte, 2013. "Investment Adjustments In Product Market Competition," International Journal of Innovation and Technology Management (IJITM), World Scientific Publishing Co. Pte. Ltd., vol. 10(05), pages 1-14.
  22. Klaus Wersching, 2010. "Schumpeterian Competition, Technological Regimes and Learning through Knowledge Spillover," Post-Print hal-00849408, HAL.
  23. Wersching, Klaus, 2010. "Schumpeterian competition, technological regimes and learning through knowledge spillover," Journal of Economic Behavior & Organization, Elsevier, vol. 75(3), pages 482-493, September.
  24. Mariana Mazzucato & Stuart Parris, 2015. "High-growth firms in changing competitive environments: the US pharmaceutical industry (1963 to 2002)," Small Business Economics, Springer, vol. 44(1), pages 145-170, January.
  25. A. Arrighetti & R. Brancati & A. Lasagni & A. Maresca, 2015. "Firms’ heterogeneity and performance in manufacturing during the great recession," Economics Department Working Papers 2015-EP03, Department of Economics, Parma University (Italy).
  26. Davide Consoli & Andrea Mina, 2009. "An evolutionary perspective on health innovation systems," Journal of Evolutionary Economics, Springer, vol. 19(2), pages 297-319, April.
  27. Andersson, Tord & Gleadle, Pauline & Haslam, Colin & Tsitsianis, Nick, 2010. "Bio-pharma: A financialized business model," CRITICAL PERSPECTIVES ON ACCOUNTING, Elsevier, vol. 21(7), pages 631-641.
  28. Ryan, Michael P., 2010. "Patent Incentives, Technology Markets, and Public-Private Bio-Medical Innovation Networks in Brazil," World Development, Elsevier, vol. 38(8), pages 1082-1093, August.
  29. Lavarello, Pablo José, 2016. "Corporate knowledge diversification in the face of technological complexity: The case of industrial biotech," Structural Change and Economic Dynamics, Elsevier, vol. 38(C), pages 95-105.
  30. Hopkins, Michael M. & Martin, Paul A. & Nightingale, Paul & Kraft, Alison & Mahdi, Surya, 2007. "The myth of the biotech revolution: An assessment of technological, clinical and organisational change," Research Policy, Elsevier, vol. 36(4), pages 566-589, May.
  31. Giovanni Dosi & Joseph Stiglitz, 2013. "The Role of Intellectual Property Rights in the Development Process, with Some Lessons from Developed Countries: An Introduction," LEM Papers Series 2013/23, Laboratory of Economics and Management (LEM), Sant'Anna School of Advanced Studies, Pisa, Italy.
  32. Catherine Lecocq & Bart Looy, 2009. "The impact of collaboration on the technological performance of regions: time invariant or driven by life cycle dynamics?," Scientometrics, Springer;Akadémiai Kiadó, vol. 80(3), pages 845-865, September.
IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.